{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:21:10Z","timestamp":1775082070572,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.urology.2017.11.039","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T22:25:18Z","timestamp":1512771918000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Intravesical Electromotive Botulinum Toxin Type \u201cA\u201d Administration for Management of Urinary Incontinence Secondary to Neuropathic Detrusor Overactivity in Children: Long-term Follow-up"],"prefix":"10.1016","volume":"114","author":[{"given":"Seyedeh-Sanam","family":"Ladi-Seyedian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-6285","authenticated-orcid":false,"given":"Abdol-Mohammad","family":"Kajbafzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2017.11.039_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.ju.0000103274.38694.b1","article-title":"Can higher doses of oxybutynin improve efficacy in neurogenic bladder?","volume":"171","author":"Bennett","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0020","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4111\/kju.2013.54.12.806","article-title":"Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects","volume":"54","author":"\u00c7etinel","year":"2013","journal-title":"Korean J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13607863.2014.922528","article-title":"Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder","volume":"19","author":"Esin","year":"2015","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.urology.2017.11.039_bib0030","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.purol.2014.06.003","article-title":"[Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly]","volume":"24","author":"Kerdraon","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0040","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","article-title":"Emerging role of botulinum toxin in the management of voiding dysfunction","volume":"171","author":"Smith","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0045","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1464-410X.2008.08287.x","article-title":"Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem","volume":"103","author":"Kajbafzadeh","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2017.11.039_bib0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.urology.2010.06.003","article-title":"Intravesical electromotive botulinum toxin type A administration\u2014part II: clinical application","volume":"77","author":"Kajbafzadeh","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.11.039_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/THC-2007-15402","article-title":"Iontophoretic drug delivery system: a review","volume":"15","author":"Semalty","year":"2007","journal-title":"Technol Health Care"},{"key":"10.1016\/j.urology.2017.11.039_bib0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005392-200102000-00032","article-title":"Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens","volume":"165","author":"Di Stasi","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0065","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0022-5347(01)63176-8","article-title":"Electromotive drug administration of lidocaine to anesthetize the bladder before intravesical capsaicin","volume":"159","author":"Dasgupta","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-5347(06)00305-3","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: report from the standardization committee of the International Children's Continence Society","volume":"176","author":"Nev\u00e9us","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/nau.22751","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society","volume":"35","author":"Austin","year":"2016","journal-title":"Neurourol Urodyn"},{"issue":"6 pt 2","key":"10.1016\/j.urology.2017.11.039_bib0080","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1097\/00005392-200106001-00047","article-title":"Simultaneous Malone antegrade continent enema and Mitrofanoff principle using the divided appendix: report of a new technique for prevention of stoma complications","volume":"165","author":"Kajbafzadeh","year":"2001","journal-title":"J Urol"},{"issue":"6 pt A","key":"10.1016\/j.urology.2017.11.039_bib0085","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jpurol.2012.08.011","article-title":"Intravesical botulinum type-A toxin (Dysport\u00ae) in the treatment of idiopathic detrusor overactivity in children","volume":"9","author":"Blackburn","year":"2013","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0090","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.juro.2011.02.004","article-title":"Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial","volume":"185","author":"Herschorn","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1179\/2045772313Y.0000000116","article-title":"Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review","volume":"36","author":"Linsenmeyer","year":"2013","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.urology.2017.11.039_bib0100","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0022-5347(01)63174-4","article-title":"Intravesical electromotive drug administration technique: preliminary results and side effects","volume":"159","author":"Riedl","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0105","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.eururo.2006.08.025","article-title":"New frontiers in intravesical therapies and drug delivery","volume":"50","author":"Giannantoni","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00383-008-2260-3","article-title":"Botulinum toxin in pediatric urology: a systematic literature review","volume":"25","author":"Dasgupta","year":"2009","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.urology.2017.11.039_bib0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1464-410X.2012.11282.x","article-title":"Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB)","volume":"111","author":"Mohee","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2017.11.039_bib0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1464-410X.2012.11285.x","article-title":"Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB)","volume":"111","author":"Goldman","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2017.11.039_bib0125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0130","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.11.039_bib0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00383-013-3365-x","article-title":"Repeated injections of intradetrusor onabotulinumtoxin A, as adjunctive treatment of children with neurogenic bladder","volume":"30","author":"Sager","year":"2014","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.urology.2017.11.039_bib0140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-5347(06)00301-6","article-title":"The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor","volume":"176","author":"Hoebeke","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.11.039_bib0145","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1111\/apa.12158","article-title":"Bladder and bowel dysfunction and the resolution of urinary incontinence with successful management of bowel symptoms in children","volume":"102","author":"Borch","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.urology.2017.11.039_bib0150","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00384-016-2514-9","article-title":"Intravesical electromotive botulinum toxin type A administration for management of concomitant neuropathic bowel and bladder dysfunction in children","volume":"31","author":"Kajbafzadeh","year":"2016","journal-title":"Int J Colorectal Dis"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517312426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429517312426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T02:01:26Z","timestamp":1603504886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429517312426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":29,"alternative-id":["S0090429517312426"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2017.11.039","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravesical Electromotive Botulinum Toxin Type \u201cA\u201d Administration for Management of Urinary Incontinence Secondary to Neuropathic Detrusor Overactivity in Children: Long-term Follow-up","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2017.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}